Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Inhaled Formulation of Melatonin to Treat Adults With Insomnia Disorder: a Randomised Open-Label Crossover Trial

NCT06802913 is registered in ClinicalTrials.gov with Woolcock Institute of Medical Research as lead sponsor.

NCT NCT06802913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06802913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Inhaled Formulation of Melatonin to Treat Adults With Insomnia Disorder: a Randomised Open-Label Crossover Trial
Lead sponsor
Woolcock Institute of Medical Research
Phase
Phase 1
Overall status
Recruiting
Start date
July 1, 2025
Completion date
May 31, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia